RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 103 filers reported holding RAPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.07 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $570,132 | -35.7% | 34,304 | -27.6% | 0.00% | – |
| Q2 2023 | $886,380 | -1.0% | 47,400 | -2.9% | 0.00% | – |
| Q1 2023 | $895,572 | -54.7% | 48,805 | -51.1% | 0.00% | -100.0% |
| Q4 2022 | $1,974,931 | +613.0% | 99,744 | +766.2% | 0.00% | – |
| Q3 2022 | $277,000 | +465.3% | 11,515 | +327.9% | 0.00% | – |
| Q2 2022 | $49,000 | -95.0% | 2,691 | -94.0% | 0.00% | – |
| Q1 2022 | $989,000 | -65.5% | 44,962 | -42.4% | 0.00% | -100.0% |
| Q4 2021 | $2,869,000 | +1386.5% | 78,113 | +1153.8% | 0.00% | – |
| Q3 2021 | $193,000 | -1.5% | 6,230 | +0.8% | 0.00% | – |
| Q2 2021 | $196,000 | -1.5% | 6,178 | -31.2% | 0.00% | – |
| Q1 2021 | $199,000 | +24.4% | 8,976 | +10.8% | 0.00% | – |
| Q4 2020 | $160,000 | -74.4% | 8,101 | -58.3% | 0.00% | – |
| Q3 2020 | $626,000 | +38.8% | 19,417 | +24.8% | 0.00% | – |
| Q2 2020 | $451,000 | +1226.5% | 15,564 | +880.1% | 0.00% | – |
| Q1 2020 | $34,000 | -58.0% | 1,588 | -45.9% | 0.00% | – |
| Q4 2019 | $81,000 | – | 2,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |